Owner and Principal Consultant @ ForwardPoint, LLC (February 2026 - July 2026)
Vice President, R and D (Toxicology, Biocompatibility, Extractable and Leachables, Material Science) @ (November 2024 - February 2026)
Vice President, Preclinical Toxicology @ (March 2022 - November 2024)
Vice President, Research and Discovery @ (April 2020 - February 2022)
Senior Director, Toxicology and Pharmacokinetics @ (August 2018 - April 2020)
Senior Director Toxicology and Preclinical Safety @ (December 2014 - August 2018)
Director, Global Product Safety @ (December 2010 - December 2014)
Senior Manager, Global Product Safety @ (June 2008 - December 2010)
Senior Toxicologist and Safety Assessment, Pharmaceutical R and D @ (September 2001 - June 2008)
Toxicologist and Professional and Regulatory Services @ (December 1999 - August 2001)
Jeffrey White Education
University of Wisconsin-Madison
PhD
1992-1999
University of Wisconsin-Madison
BS
1987-1992
Jeffrey White Skills
Biotechnology
Chemistry
Clinical Development
Clinical Research
Consumer Products
Drug Development
Exposure Assessment
FDA
Formulation
GLP
GMP
Good Laboratory Practice (GLP)
In Vivo
Life Sciences
Lifesciences
Medical Devices
Pharmaceutical Industry
R&D
Regulatory Affairs
Regulatory Submissions
Risk Assessment
SOP
Toxicology
Validation
Jeffrey White Summary
Jeffrey White, based in Lake Forest, IL, US, is currently a Director, Nonclinical Safety and Portfolio Strategy at AbbVie. Jeffrey White brings experience from previous roles at ForwardPoint, LLC, Baxter International Inc. and Aerie Pharmaceuticals. Jeffrey White holds a 1992 - 1999 PhD @ University of Wisconsin-Madison. With a robust skill set that includes Biotechnology, Chemistry, Clinical Development, Clinical Research, Consumer Products and more. Jeffrey White has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Jeffrey White?
Find contact details for 700 million professionals.